Lyra Health Expands Substance Use Disorder Support Nationwide
Lyra Health, a leading provider of Workforce Mental Health solutions, has expanded its services to support members struggling with substance use disorders (SUD) related to cannabis, stimulants, opioids, and nicotine. Building on the success of its Lyra Renew program for alcohol use disorder, the company’s expansion now offers evidence-based, personalized care for a wider range of SUDs...
Lyra Health, a leading provider of Workforce Mental Health solutions, has expanded its services to support members struggling with substance use disorders (SUD) related to cannabis, stimulants, opioids, and nicotine. Building on the success of its Lyra Renew program for alcohol use disorder, the company’s expansion now offers evidence-based, personalized care for a wider range of SUDs. This comprehensive program, available to all U.S. members, addresses both substance use and co-occurring mental health conditions through virtual therapy, digital tools, and peer recovery support. Lyra’s integrated approach aims to break the cycle of relapse and ensure long-term recovery.
Lyra Health serves more than 17 million people worldwide, helping employees and their families manage mental health and addiction challenges. Its AI-powered platform connects individuals with the largest global network of mental health providers, offering evidence-based treatments proven to reduce healthcare costs by 26% annually for participants. The company also introduced a new Nicotine Quitline to replace traditional cessation programs, providing personalized support for members to quit tobacco. Lyra’s innovative care model delivers faster recovery times and has demonstrated significant improvements in mental health outcomes and cost savings for employers, positioning it as a leader in mental health and substance use care.
